Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease

By Stayner Cherie   Iglesias Diana M.   Goodyer Paul R.   Ellis Lana   Germino Greg   Zhou Jing   Eccles Michael R.  

Human Molecular Genetics, Vol. 18, Iss. 8, 2009-04 ,pp. : 1543-1543

Oxford University Press

Access to resources Recommend Favorite

Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease

By Stayner Cherie   Iglesias Diana M.   Goodyer Paul R.   Ellis Lana   Germino Greg   Zhou Jing   Eccles Michael R.  

Human Molecular Genetics, Vol. 15, Iss. 24, 2006-12 ,pp. : 3520-3528

Oxford University Press

Access to resources Recommend Favorite

Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer

By Lang D.   Epstein J.A.  

Human Molecular Genetics, Vol. 12, Iss. 8, 2003-04 ,pp. : 937-945

Oxford University Press

Access to resources Recommend Favorite

Genetic dissection of Pax6 dosage requirements in the developing mouse eye

By Davis-Silberman Noa  

Human Molecular Genetics, Vol. 14, Iss. 15, 2005-08 ,pp. : 2265-2276

Oxford University Press

Access to resources Recommend Favorite

Reduction of Pax9 gene dosage in an allelic series of mouse mutants causes hypodontia and oligodontia

By Kist Ralf   Watson Michelle   Wang Xiaomeng   Cairns Paul   Miles Colin   Reid Donald J.   Peters Heiko  

Human Molecular Genetics, Vol. 14, Iss. 23, 2005-12 ,pp. : 3605-3617

Oxford University Press

Access to resources Recommend Favorite